Selected stock price target news of the day - September 26, 2023

By: Matthew Otto

My Special Aflac Duck Brings Comfort to Children

In alignment with National Childhood Cancer Awareness and Sickle Cell Awareness Month, Aflac delivered its innovative My Special Aflac Duck to children at The University of New Mexico Children’s Hospital in Albuquerque. This social robot is designed to provide emotional support and comfort to children grappling with pediatric cancer and blood disorders like sickle cell disease. Developed following extensive research involving children, families, and healthcare providers, the My Special Aflac Duck has already brought joy and solace to over 24,000 children across the United States, Japan, and Northern Ireland.

The My Special Aflac Duck is not just a toy but a sophisticated companion for children during their challenging medical journeys. It engages through medical play, lifelike movements, and emotional mimicry, helping kids cope with the emotional aspects of their treatments. Aflac’s commitment to children and families facing these medical challenges, spanning more than 28 years with a $170 million investment.

Analyst Price Target for Aflac Upgraded

Raymond James analyst Wilma Burdis maintained an Outperform rating and raised the price target from $77 to $83.

Which Analyst has the best track record to show on AFL?

Analyst Mark Hughes (TRUIST) currently has the highest performing score on AFL with 8/9 (88.89%) price target fulfillment ratio. His price targets carry an average of $5.36 (17.13%) potential upside. Aflac stock price reaches these price targets on average within 547 days.

DraftKings Receives Bullish Outlook Amidst Industry Growth

DraftKings has received an upgraded outlook from J.P. Morgan analyst Joseph Greff. Greff upgraded the stock from Neutral to Overweight and established a year-end 2024 price target of $37, replacing the previous target of $26 for year-end 2023. The analyst’s optimism is rooted in DraftKings’ attractive business model within the online sports betting industry and its competitive position. He also highlights the overall appeal of the gambling sector, driven by growth prospects and improved expense management across the industry.

Greff’s analysis underscores DraftKings’ strong moat, which includes factors such as its product offerings, scale, and brand recognition. This moat is expected to enable DraftKings to effectively compete against new entrants in the market, such as PENN’s ESPNBet and Fanatics. The company’s stock had surged 140% earlier in the year, and fiscal second-quarter revenue showed an 88% increase year-over-year.

Analysts Bullish on DraftKings, Set Higher Price Targets

Benchmark analyst Mike Hickey reiterated a Buy rating and a $37 price target.
J.P. Morgan analyst Joseph Greff upgraded from Neutral to Overweight and the price target from $26 to $37.

Which Analyst has the best track record to show on DKNG?

Analyst Shaun Kelley (BAML) currently has the highest performing score on DKNG with 5/6 (83.33%) price target fulfillment ratio. His price targets carry an average of $4.15 (11.85%) potential upside. DraftKings stock price reaches these price targets on average within 104 days.

Cintas Reports Q1 2024 Performance and Raises Annual Guidance

Cintas Corporation has announced financial results for the first quarter of fiscal year 2024, ending August 31, 2023. The company reported 8.1% increase in revenue compared to the same quarter in the previous year, reaching $2.34 billion. The company’s gross margin, which increased by 11.0% to $1.14 billion. This increase in gross margin as a percentage of revenue, up to 48.7%, demonstrates Cintas’ ability to manage costs effectively. Moreover, the company’s operating income rose by 13.7%, reaching $500.6 million in the first quarter of fiscal 2024, with an operating margin of 21.4%.

Cintas’ Q1 results have prompted an upward revision of its full fiscal year 2024 guidance. The company now anticipates annual revenue to fall within the range of $9.40 billion to $9.52 billion, up from the previous estimate of $9.35 billion to $9.50 billion. Similarly, diluted earnings per share (EPS) guidance has been raised to a range of $14.00 to $14.45, up from $13.85 to $14.35.

Analysts Provide Mixed Recommendations for Goldman Sachs Group

Odeon Capital analyst Dick Bove upgrades from Hold to Buy with a $355.75 price target.
Societe Generale analyst Andrew Lim downgrades from Buy to Hold.
JMP Securities analyst Devin Ryan maintains a Market Outperform rating and lowers the price target from $470 to $450.
JP Morgan analyst Kian Abouhossein reiterates an Overweight rating and lowers the price target from $415 to $398.

Which Analyst has the best track record to show on CTAS?

Analyst Gary Bisbee (BAML) currently has the highest performing score on CTAS with 5/6 (83.33%) price target fulfillment ratio. His price targets carry an average of $28.78 (11.90%) potential upside. Cintas stock price reaches these price targets on average within 60 days.